Metabolomic profiling identifies novel biomarkers and mechanisms in human bladder cancer treated with submucosal injection of gemcitabine

Bladder cancer (BCa) is a common urinary tract malignancy with frequent recurrences after initial resection. Submucosal injection of gemcitabine prior to transurethral resection of bladder tumor (TURBT) may prevent recurrence of urothelial cancer. However, the underlying mechanism remains unknown. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chao, Sun, Xian, Wang, Hengbing, Lu, Ting, Wu, Keqing, Guan, Yusheng, Tang, Jing, Liang, Jian, Sun, Rongli, Guo, Zhongying, Zheng, Sinian, Wu, Xiaoli, Jiang, Hesong, Jiang, Xi, Zhong, Bing, Niu, Xiaobing, Sun, Suan, Wang, Xinru, Chen, Minjian, Fu, Guangbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777689/
https://www.ncbi.nlm.nih.gov/pubmed/31545404
http://dx.doi.org/10.3892/ijmm.2019.4347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777689/
https://www.ncbi.nlm.nih.gov/pubmed/31545404
http://dx.doi.org/10.3892/ijmm.2019.4347

Ejemplares similares